European Morning Report: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on European Morning Report.

Press releases published on August 4, 2026

Aug. 4, 2026

DEEP SEA MINERALS CORP. FILES FORM F-10 REGISTRATION STATEMENT WITH U.S. SECURITIES AND EXCHANGE COMMISSION BECOMING A U.S. REPORTING COMPANY

Indeterminate GlobeNewswire

Aug. 4, 2026

NIOB cuts target pegmatite in all Bardy holes

Indeterminate GlobeNewswire

Aug. 4, 2026

The Smurfs Have Arrived in Talking Tom & Friends: World

Indeterminate GlobeNewswire

Aug. 4, 2026

Sustainability LIVE: The London Summit to Host Industry Leaders on Net Zero and Decarbonisation

Indeterminate GlobeNewswire

Aug. 4, 2026

Invivyd Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) 

Indeterminate GlobeNewswire

Aug. 4, 2026

Rhythm Pharmaceuticals Reports Second Quarter 2026 Financial Results and Business Update

Indeterminate GlobeNewswire

Aug. 4, 2026

CAMP4 Therapeutics Announces Second Closing of $100 Million Private Placement

Indeterminate GlobeNewswire

Aug. 4, 2026

Lisata Therapeutics Provides Update Following Termination of Merger Agreement

Indeterminate GlobeNewswire

Aug. 4, 2026

Arvinas Reports Second Quarter 2026 Financial Results and Provides Corporate Update

Indeterminate GlobeNewswire

Aug. 4, 2026

Odyssey Therapeutics Reports Second Quarter 2026 Financial Results and Provides Corporate Update

Indeterminate GlobeNewswire

Aug. 4, 2026

Tiziana Life Sciences Announces Purchase of Shares by Chief Executive Officer

Indeterminate GlobeNewswire

Aug. 4, 2026

Vantage Biosciences Completes Enrollment in Phase 2 SeeClear Study of Oral Oruvestat in Non-Proliferative Diabetic Retinopathy

Indeterminate GlobeNewswire

Aug. 4, 2026

Rhythm Pharmaceuticals Announces Preliminary Data from Phase 2 Trial that Showed RM-718 Demonstrated Positive Efficacy Signal in Acquired Hypothalamic Obesity

Indeterminate GlobeNewswire

Aug. 4, 2026

BioNTech veröffentlicht Ergebnisse für das zweite Quartal 2026 sowie Informationen zur Geschäftsentwicklung

Indeterminate GlobeNewswire

Aug. 4, 2026

BioNTech Announces Second Quarter 2026 Financial Results and Corporate Update

Indeterminate GlobeNewswire

Aug. 4, 2026

Transaction in Own Shares

Indeterminate GlobeNewswire

Aug. 4, 2026

CervoMed Announces Neflamapimod Awarded Innovation Passport Designation Under the UK Innovative Licensing and Access Pathway (ILAP) for Treatment of Dementia with Lewy Bodies (DLB)

Indeterminate GlobeNewswire

Aug. 4, 2026

Virtune AB (Publ) ("Virtune") has completed the monthly rebalancing for July 2026 of its Virtune Crypto Top 10 Index ETP - the first crypto index ETP in the Nordics

Indeterminate GlobeNewswire

Aug. 4, 2026

Virtune AB (Publ) (“Virtune”) har genomfört den månatliga rebalanseringen för juli 2026 av Virtune Crypto Top 10 Index ETP, Nordens första kryptoindex-ETP

Indeterminate GlobeNewswire

Aug. 4, 2026

Die weltweit besten alternativen Reiseziele abseits des Massentourismus

Indeterminate GlobeNewswire